Association of ADIPOQ and ADIPOR Variants with Risk of Colorectal Cancer:A Meta-analysis

Numerous epidemiological studies have studied the association of adiponectin(ADIPOQ) gene and adiponectin receptor(ADIPOR) gene polymorphisms with risk of colorectal cancer(CRC),but the outcomes were incomplete and inconsistent.Therefore,we conducted a meta-analysis to assess the associations system...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 37; no. 2; pp. 161 - 171
Main Author 谭璇 王国斌 唐勇 白洁 叶霖
Format Journal Article
LanguageEnglish
Published Wuhan Huazhong University of Science and Technology 01.04.2017
Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China%Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
1993-1352
DOI10.1007/s11596-017-1710-3

Cover

Loading…
Abstract Numerous epidemiological studies have studied the association of adiponectin(ADIPOQ) gene and adiponectin receptor(ADIPOR) gene polymorphisms with risk of colorectal cancer(CRC),but the outcomes were incomplete and inconsistent.Therefore,we conducted a meta-analysis to assess the associations systematically.All eligible case-control studies published up to Jan.2015 were searched from Pub Med,the Cochrane library,Elsevier,Wiley Online library,China National Knowledge Infrastructure,Wan Fang data and Chongqing VIP.Effect sizes of odds ratio(OR) and 95% confidence interval(95%CI) were calculated by using a fixed-or random-effect model.Twelve case-control studies including 6141 cases and 7398 controls were selected.Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766,rs1501299 and ADIPOR variant rs1342387.In stratified analysis for different populations,significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish,in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese.In addition,the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC.ADIPOQ variants rs2241766 T/G,rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk,which may be mediated by insulin resistance.And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538,especially for their interaction and combined effect in the correlation with CRC risk.
AbstractList Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of colorectal cancer (CRC),but the outcomes were incomplete and inconsistent.Therefore,we conducted a meta-analysis to assess the associations systematically.All eligible case-control studies published up to Jan.2015 were searched from PubMed,the Cochrane library,Elsevier,Wiley Online library,China National Knowledge Infrastructure,WanFang data and Chongqing VIP.Effect sizes of odds ratio (OR) and 95% confidence interval (95%CI) were calculated by using a fixed-or random-effect model.Twelve case-control studies including 6141 cases and 7398 controls were selected.Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766,rs1501299 and ADIPOR variant rs1342387.In stratified analysis for different populations,significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish,in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese.In addition,the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC.ADIPOQ variants rs2241766 T/G,rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk,which may be mediated by insulin resistance.And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538,especially for their interaction and combined effect in the correlation with CRC risk.
Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of colorectal cancer (CRC), but the outcomes were incomplete and inconsistent. Therefore, we conducted a meta-analysis to assess the associations systematically. All eligible case-control studies published up to Jan. 2015 were searched from PubMed, the Cochrane library, Elsevier, Wiley Online library, China National Knowledge Infrastructure, WanFang data and Chongqing VIP. Effect sizes of odds ratio (OR) and 95% confidence interval (95%CI) were calculated by using a fixed- or random-effect model. Twelve case-control studies including 6141 cases and 7398 controls were selected. Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766, rs1501299 and ADIPOR variant rs1342387. In stratified analysis for different populations, significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish, in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese. In addition, the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC. ADIPOQ variants rs2241766 T/G, rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk, which may be mediated by insulin resistance. And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538, especially for their interaction and combined effect in the correlation with CRC risk.Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of colorectal cancer (CRC), but the outcomes were incomplete and inconsistent. Therefore, we conducted a meta-analysis to assess the associations systematically. All eligible case-control studies published up to Jan. 2015 were searched from PubMed, the Cochrane library, Elsevier, Wiley Online library, China National Knowledge Infrastructure, WanFang data and Chongqing VIP. Effect sizes of odds ratio (OR) and 95% confidence interval (95%CI) were calculated by using a fixed- or random-effect model. Twelve case-control studies including 6141 cases and 7398 controls were selected. Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766, rs1501299 and ADIPOR variant rs1342387. In stratified analysis for different populations, significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish, in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese. In addition, the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC. ADIPOQ variants rs2241766 T/G, rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk, which may be mediated by insulin resistance. And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538, especially for their interaction and combined effect in the correlation with CRC risk.
Numerous epidemiological studies have studied the association of adiponectin(ADIPOQ) gene and adiponectin receptor(ADIPOR) gene polymorphisms with risk of colorectal cancer(CRC),but the outcomes were incomplete and inconsistent.Therefore,we conducted a meta-analysis to assess the associations systematically.All eligible case-control studies published up to Jan.2015 were searched from Pub Med,the Cochrane library,Elsevier,Wiley Online library,China National Knowledge Infrastructure,Wan Fang data and Chongqing VIP.Effect sizes of odds ratio(OR) and 95% confidence interval(95%CI) were calculated by using a fixed-or random-effect model.Twelve case-control studies including 6141 cases and 7398 controls were selected.Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766,rs1501299 and ADIPOR variant rs1342387.In stratified analysis for different populations,significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish,in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese.In addition,the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC.ADIPOQ variants rs2241766 T/G,rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk,which may be mediated by insulin resistance.And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538,especially for their interaction and combined effect in the correlation with CRC risk.
Summary Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of colorectal cancer (CRC), but the outcomes were incomplete and inconsistent. Therefore, we conducted a meta-analysis to assess the associations systematically. All eligible case-control studies published up to Jan. 2015 were searched from PubMed, the Cochrane library, Elsevier, Wiley Online library, China National Knowledge Infrastructure, WanFang data and Chongqing VIP. Effect sizes of odds ratio (OR) and 95% confidence interval (95%CI) were calculated by using a fixed- or random-effect model. Twelve case-control studies including 6141 cases and 7398 controls were selected. Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766, rs1501299 and ADIPOR variant rs1342387. In stratified analysis for different populations, significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish, in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese. In addition, the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC. ADIPOQ variants rs2241766 T/G, rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk, which may be mediated by insulin resistance. And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538, especially for their interaction and combined effect in the correlation with CRC risk.
Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of colorectal cancer (CRC), but the outcomes were incomplete and inconsistent. Therefore, we conducted a meta-analysis to assess the associations systematically. All eligible case-control studies published up to Jan. 2015 were searched from PubMed, the Cochrane library, Elsevier, Wiley Online library, China National Knowledge Infrastructure, WanFang data and Chongqing VIP. Effect sizes of odds ratio (OR) and 95% confidence interval (95%CI) were calculated by using a fixed- or random-effect model. Twelve case-control studies including 6141 cases and 7398 controls were selected. Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766, rs1501299 and ADIPOR variant rs1342387. In stratified analysis for different populations, significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish, in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese. In addition, the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC. ADIPOQ variants rs2241766 T/G, rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk, which may be mediated by insulin resistance. And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538, especially for their interaction and combined effect in the correlation with CRC risk.
Author 谭璇 王国斌 唐勇 白洁 叶霖
AuthorAffiliation Department of Ophthalmology, Union Hospital, Tongii Medical College, Huazhong University of Science and Technology,Wuhan 430022, China Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science andTechnology, Wuhan 430022, China
AuthorAffiliation_xml – name: Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China%Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Author_xml – sequence: 1
  fullname: 谭璇 王国斌 唐勇 白洁 叶霖
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28397042$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1uFDEQhS0URH7gAGxQixVS1FBlT7fby9EASaREgQhYsLHcbvfEkx47sT1K5iqchTvlCnjoSZBYZOVafM-vql7tkx3nnSHkNcJ7BOAfImIl6hKQl8gRSvaM7KEQrERW0Z1c15yWwBnbJfsxLgAqXtPJC7JLGyY4TOge-TmN0WurkvWu8H0x_Xjy5fxroVw3lhfFDxWscikWtzZdFhc2Xm24mR98MDqpoZgpp024__1rWpyZpErl1LCONr4kz3s1RPNq-x6Q758_fZsdl6fnRyez6WmpJ8BTWTUdKqUnLai2bkF0CLRpUahGaIqirnttsAVA6I2Aqu5awasuz8zrVptesANyOP57q1yv3Fwu_CrkHqJMi_VVd3fXSkMzDxSAZvrdSF8Hf7MyMcmljdoMg3LGr6LEpql5xaDBjL7Zoqt2aTp5HexShbV82F4GcAR08DEG0z8iCHKTkBwTktldbhKSLGv4fxpt09_1p6Ds8KSSjsqYXdzchH-DPiV6u7W79G5-k3WPPebjoNAAMPYH_2auoA
CitedBy_id crossref_primary_10_1007_s00394_022_02845_8
crossref_primary_10_1016_j_metabol_2018_08_003
crossref_primary_10_1007_s11596_019_2105_4
crossref_primary_10_1155_2020_7802498
crossref_primary_10_12998_wjcc_v8_i4_736
crossref_primary_10_7717_peerj_10682
Cites_doi 10.2307/2533446
10.1210/me.2009-0498
10.1007/s11033-012-2154-2
10.1089/gtmb.2014.0238
10.1016/j.metabol.2011.03.020
10.1002/gepi.20410
10.1007/s10552-012-9981-2
10.1089/gtmb.2013.0493
10.1016/j.metabol.2015.06.013
10.1002/sim.4780060325
10.7150/ijms.6843
10.1007/s00125-003-1074-z
10.1007/s13277-012-0606-x
10.1186/s12881-014-0137-y
10.1136/bmj.327.7414.557
10.1530/EJE-09-0492
10.1136/bmj.315.7121.1533
10.1001/jama.300.13.1523
10.1007/s13277-013-1329-3
10.1038/nrc2222
10.1186/1471-2350-12-94
10.1002/sim.1186
10.1371/journal.pone.0067275
10.1530/EJE-09-0039
10.1093/hmg/ddp109
10.3233/CBM-2010-0154
10.7314/APJCP.2014.15.18.7515
10.1038/oby.2005.91
10.1007/s10552-009-9427-7
10.1016/0197-2456(86)90046-2
10.1038/bjc.2011.259
10.3892/ol.2011.443
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2017
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2017
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-017-1710-3
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Association of ADIPOQ and ADIPOR Variants with Risk of Colorectal Cancer:A Meta-analysis
EISSN 1993-1352
EndPage 171
ExternalDocumentID tjykdxxb_e201702002
28397042
10_1007_s11596_017_1710_3
672208003
Genre Meta-Analysis
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China; the first Young Talents Foundation of Hubei Province; Hubei Province Health and Family Planning Scientific Research Project; the Fundamental Research Funds for the Central Universities; Natural Science Foundation of Hubei Province
  funderid: (81301691); (2014); (WJ2017Q023 and WJ2017M113); (2015LC029); (2016CFB356)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
DPUIP
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
ABQSL
H13
AAYXX
ADHKG
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
93N
PSX
ID FETCH-LOGICAL-c407t-58d1aac4b0ab6b09d1028b19a89c21966fce1b0010fe9056db975d01776bcef93
IEDL.DBID U2A
ISSN 1672-0733
1993-1352
IngestDate Thu May 29 04:06:48 EDT 2025
Fri Jul 11 15:20:27 EDT 2025
Thu Apr 03 07:00:25 EDT 2025
Tue Jul 01 00:22:00 EDT 2025
Thu Apr 24 23:05:49 EDT 2025
Fri Feb 21 02:37:18 EST 2025
Wed Feb 14 10:01:55 EST 2024
IsPeerReviewed false
IsScholarly false
Issue 2
Keywords adiponectin receptor gene
adiponectin gene
colorectal cancer
single nucleotide polymorphisms
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c407t-58d1aac4b0ab6b09d1028b19a89c21966fce1b0010fe9056db975d01776bcef93
Notes Xuan TAN 1, Guo-bin WANG 2, Yong TANG 2, Jie BAI 2, Lin YE 2( 1Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China 2Department of Gastrointestinal Surgery, Union Hospital, Tongii Medical College, Huazhong University of Science and Technology, Wuhan 430022, China)
42-1679/R
adiponectin gene adiponectin receptor gene single nucleotide polymorphisms colorectal cancer
Numerous epidemiological studies have studied the association of adiponectin(ADIPOQ) gene and adiponectin receptor(ADIPOR) gene polymorphisms with risk of colorectal cancer(CRC),but the outcomes were incomplete and inconsistent.Therefore,we conducted a meta-analysis to assess the associations systematically.All eligible case-control studies published up to Jan.2015 were searched from Pub Med,the Cochrane library,Elsevier,Wiley Online library,China National Knowledge Infrastructure,Wan Fang data and Chongqing VIP.Effect sizes of odds ratio(OR) and 95% confidence interval(95%CI) were calculated by using a fixed-or random-effect model.Twelve case-control studies including 6141 cases and 7398 controls were selected.Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766,rs1501299 and ADIPOR variant rs1342387.In stratified analysis for different populations,significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish,in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese.In addition,the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC.ADIPOQ variants rs2241766 T/G,rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk,which may be mediated by insulin resistance.And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538,especially for their interaction and combined effect in the correlation with CRC risk.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 28397042
PQID 1886753081
PQPubID 23479
PageCount 11
ParticipantIDs wanfang_journals_tjykdxxb_e201702002
proquest_miscellaneous_1886753081
pubmed_primary_28397042
crossref_primary_10_1007_s11596_017_1710_3
crossref_citationtrail_10_1007_s11596_017_1710_3
springer_journals_10_1007_s11596_017_1710_3
chongqing_primary_672208003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-04-01
PublicationDateYYYYMMDD 2017-04-01
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Wuhan
PublicationPlace_xml – name: Wuhan
– name: China
PublicationSubtitle Medical Sciences
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAbbrev J. Huazhong Univ. Sci. Technol. [Med. Sci.]
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL Journal of Huazhong University of Science and Technology(Medical Science)
PublicationYear 2017
Publisher Huazhong University of Science and Technology
Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China%Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China%Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
References Kim, Lee, Kim (CR3) 2010; 24
Zhang, Feng, Liu (CR26) 2012; 22
Menendez, Lupu (CR1) 2007; 7
Cnop, Havel, Utzschneider (CR2) 2003; 46
Al-Harithy, Al-Zahrani (CR29) 2012; 3
Li, Ma, Sang (CR5) 2014; 18
Egger, Smith, Phillips (CR17) 1997; 315
Higgins, Thompson (CR12) 2002; 21
Li, Liu, Feng (CR20) 2014; 35
Higgins, Thompson, Deeks (CR13) 2003; 327
Demets (CR15) 1987; 6
Hu, Yuan, Yan (CR19) 2013; 8
Fan, Wen, Xu (CR6) 2013; 34
Yu, Zhou, Liu (CR9) 2014; 15
Partida-Perez, Ayala-Madrigal, Peregrina-Sandoval (CR28) 2010; 7
Begg, Mazumdar (CR16) 1994; 50
Keku, Vidal, Oliver (CR18) 2012; 23
Gialamas, Petridou, Tseleni-Balafouta (CR30) 2011; 60
Ye, Wang, Tan (CR7) 2013; 10
Der Simonian, Laird (CR14) 1986; 7
Ou, Chen, Zhou (CR27) 2014; 15
Liu, Zhong, Wei (CR23) 2011; 6
Guo, Liu, You (CR21) 2015; 19
Yoon, Keum, Zhang (CR33) 2015; 64
He, Pan, Zhang (CR32) 2011; 12
Melistas, Mantzoros, Kontogianni (CR34) 2009; 161
Pechlivanis, Bermejo, Pardini (CR22) 2009; 160
Kaklamani, Wisinski, Sadim (CR10) 2008; 300
Gornick, Rennert, Moreno (CR25) 2011; 105
Little, Higgins, Ioannidis (CR11) 2009; 33
Gonzalez-Sanchez, Zabena, Martinez-Larrad (CR31) 2005; 13
Xu, He, Pan (CR4) 2013; 40
Li, Liu, Li (CR8) 2014; 35
Tsilidis, Helzlsouer, Smith (CR24) 2009; 20
Carvajal-Carmona, Spain, Consortium (CR35) 2009; 18
P Li (1710_CR8) 2014; 35
M d l L Partida-Perez (1710_CR28) 2010; 7
JA Menendez (1710_CR1) 2007; 7
YS Yoon (1710_CR33) 2015; 64
Y Xu (1710_CR4) 2013; 40
Y Ou (1710_CR27) 2014; 15
AY Kim (1710_CR3) 2010; 24
X Li (1710_CR20) 2014; 35
M Egger (1710_CR17) 1997; 315
LG Carvajal-Carmona (1710_CR35) 2009; 18
DL Demets (1710_CR15) 1987; 6
L Melistas (1710_CR34) 2009; 161
L Liu (1710_CR23) 2011; 6
J Little (1710_CR11) 2009; 33
MC Gornick (1710_CR25) 2011; 105
C Ye (1710_CR7) 2013; 10
X Guo (1710_CR21) 2015; 19
M Cnop (1710_CR2) 2003; 46
KK Tsilidis (1710_CR24) 2009; 20
Y Zhang (1710_CR26) 2012; 22
HJ Fan (1710_CR6) 2013; 34
LX Yu (1710_CR9) 2014; 15
SP Gialamas (1710_CR30) 2011; 60
JP Higgins (1710_CR13) 2003; 327
X Hu (1710_CR19) 2013; 8
RN Al-Harithy (1710_CR29) 2012; 3
VG Kaklamani (1710_CR10) 2008; 300
JP Higgins (1710_CR12) 2002; 21
B He (1710_CR32) 2011; 12
R Der Simonian (1710_CR14) 1986; 7
CB Begg (1710_CR16) 1994; 50
JL Gonzalez-Sanchez (1710_CR31) 2005; 13
Q Li (1710_CR5) 2014; 18
S Pechlivanis (1710_CR22) 2009; 160
TO Keku (1710_CR18) 2012; 23
19278015 - Genet Epidemiol. 2009 Nov;33(7):581-98
17882277 - Nat Rev Cancer. 2007 Oct;7(10):763-77
26169471 - Metabolism. 2015 Oct;64(10):1324-33
12111919 - Stat Med. 2002 Jun 15;21(11):1539-58
12687327 - Diabetologia. 2003 Apr;46(4):459-69
7786990 - Biometrics. 1994 Dec;50(4):1088-101
22740876 - Oncol Lett. 2012 Jan;3(1):176-180
24293390 - Tumour Biol. 2014 Mar;35(3):2491-6
21749709 - BMC Med Genet. 2011 Jul 12;12:94
19755407 - Eur J Endocrinol. 2009 Dec;161(6):845-52
24720830 - Genet Test Mol Biomarkers. 2014 Jun;18(6):417-24
24739564 - Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Feb;35(2):195-9
22565227 - Cancer Causes Control. 2012 Jul;23(7):1127-38
18827209 - JAMA. 2008 Oct 1;300(13):1523-31
23869187 - Int J Med Sci. 2013 Jul 04;10(9):1113-20
21829206 - Br J Cancer. 2011 Aug 9;105(4):562-4
19264763 - Hum Mol Genet. 2009 May 15;18(10 ):1889-92
25516230 - BMC Med Genet. 2014 Dec 17;15:137
23225349 - Tumour Biol. 2013 Apr;34(2):769-78
23826253 - PLoS One. 2013 Jun 27;8(6):e67275
25489716 - Genet Test Mol Biomarkers. 2015 Jan;19(1):9-13
25292021 - Asian Pac J Cancer Prev. 2014;15(18):7515-20
3802833 - Control Clin Trials. 1986 Sep;7(3):177-88
9432252 - BMJ. 1997 Dec 6;315(7121):1533-7
19760027 - Cancer Causes Control. 2009 Nov;20(9):1739-51
21263187 - Cancer Biomark. 2010;7(3):117-21
21632074 - Metabolism. 2011 Nov;60(11):1530-8
20444885 - Mol Endocrinol. 2010 Jul;24(7):1441-52
15919831 - Obes Res. 2005 May;13(5):807-12
23065236 - Mol Biol Rep. 2013 Feb;40(2):1135-44
22087284 - PLoS One. 2011;6(11):e27301
3616287 - Stat Med. 1987 Apr-May;6(3):341-50
19273568 - Eur J Endocrinol. 2009 Jun;160(6):933-40
12958120 - BMJ. 2003 Sep 6;327(7414):557-60
References_xml – volume: 50
  start-page: 1088
  issue: 4
  year: 1994
  end-page: 1101
  ident: CR16
  article-title: Operating characteristics of a rank correlation test for publication bias
  publication-title: Biometrics
  doi: 10.2307/2533446
– volume: 24
  start-page: 1441
  issue: 7
  year: 2010
  end-page: 1452
  ident: CR3
  article-title: Adiponectin represses colon cancer cell proliferation via AdipoR1-and -R2-mediated AMPK activation
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2009-0498
– volume: 40
  start-page: 1135
  issue: 2
  year: 2013
  end-page: 1144
  ident: CR4
  article-title: The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-012-2154-2
– volume: 19
  start-page: 9
  issue: 1
  year: 2015
  end-page: 13
  ident: CR21
  article-title: Association between adiponectin polymorphisms and the risk of colorectal cancer
  publication-title: Genet Test Mol Biomarkers
  doi: 10.1089/gtmb.2014.0238
– volume: 6
  start-page: 273015
  issue: 11
  year: 2011
  ident: CR23
  article-title: Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer
  publication-title: PLoS One
– volume: 60
  start-page: 1530
  issue: 11
  year: 2011
  end-page: 1158
  ident: CR30
  article-title: Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2011.03.020
– volume: 33
  start-page: 581
  issue: 7
  year: 2009
  end-page: 598
  ident: CR11
  article-title: STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement
  publication-title: Genet Epidemiol
  doi: 10.1002/gepi.20410
– volume: 23
  start-page: 1127
  issue: 7
  year: 2012
  end-page: 1138
  ident: CR18
  article-title: Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-012-9981-2
– volume: 18
  start-page: 417
  issue: 6
  year: 2014
  end-page: 424
  ident: CR5
  article-title: Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis
  publication-title: Genet Test Mol Biomarkers
  doi: 10.1089/gtmb.2013.0493
– volume: 64
  start-page: 1324
  issue: 10
  year: 2015
  end-page: 1333
  ident: CR33
  article-title: Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2015.06.013
– volume: 6
  start-page: 341
  issue: 3
  year: 1987
  end-page: 350
  ident: CR15
  article-title: Methods for combining randomized clinical trials: strengths and limitations
  publication-title: Stat Med
  doi: 10.1002/sim.4780060325
– volume: 10
  start-page: 1113
  issue: 9
  year: 2013
  end-page: 1120
  ident: CR7
  article-title: Meta-analysis of adiponectin polymorphisms and colorectal cancer risk
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.6843
– volume: 46
  start-page: 459
  issue: 4
  year: 2003
  end-page: 469
  ident: CR2
  article-title: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1074-z
– volume: 34
  start-page: 769
  issue: 2
  year: 2013
  end-page: 778
  ident: CR6
  article-title: Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis
  publication-title: Tumour Biol
  doi: 10.1007/s13277-012-0606-x
– volume: 35
  start-page: 195
  issue: 2
  year: 2014
  end-page: 199
  ident: CR20
  article-title: Association between adiponectin rs2241766, rs1501299 polymorphisms and the risk of colorectal cancer
  publication-title: Zhonghua Liu Xing Bing Xue Za Zhi (Chinese)
– volume: 15
  start-page: 1375
  issue: 1
  year: 2014
  ident: CR27
  article-title: Associations between variants on ADIPOQ and ADIPOR1 with colorectal cancer risk: a Chinese case-control study and updated meta-analysis
  publication-title: BMC Med Genet
  doi: 10.1186/s12881-014-0137-y
– volume: 327
  start-page: 557
  issue: 7414
  year: 2003
  end-page: 560
  ident: CR13
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
– volume: 161
  start-page: 845
  issue: 6
  year: 2009
  end-page: 852
  ident: CR34
  article-title: Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0492
– volume: 315
  start-page: 1533
  issue: 7121
  year: 1997
  end-page: 1537
  ident: CR17
  article-title: Meta-analysis: principles and procedures
  publication-title: BMJ
  doi: 10.1136/bmj.315.7121.1533
– volume: 300
  start-page: 1523
  issue: 13
  year: 2008
  end-page: 1531
  ident: CR10
  article-title: Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk
  publication-title: JAMA
  doi: 10.1001/jama.300.13.1523
– volume: 35
  start-page: 2491
  issue: 3
  year: 2014
  end-page: 2496
  ident: CR8
  article-title: An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-1329-3
– volume: 7
  start-page: 763
  issue: 10
  year: 2007
  end-page: 777
  ident: CR1
  article-title: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2222
– volume: 12
  start-page: 94
  year: 2011
  ident: CR32
  article-title: Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population
  publication-title: BMC Med Genet
  doi: 10.1186/1471-2350-12-94
– volume: 21
  start-page: 1539
  issue: 11
  year: 2002
  end-page: 1558
  ident: CR12
  article-title: Quantifying heterogeneity in a meta-analysis
  publication-title: Stat Med
  doi: 10.1002/sim.1186
– volume: 8
  start-page: e67275
  issue: 6
  year: 2013
  ident: CR19
  article-title: Gene Polymorphisms of +45T>G, -866G>A, and Ala54Thr on the risk of colorectal cancer: a matched case-control study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0067275
– volume: 160
  start-page: 933
  issue: 6
  year: 2009
  end-page: 940
  ident: CR22
  article-title: Genetic variation in adipokine genes and risk of colorectal cancer
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0039
– volume: 18
  start-page: 1889
  issue: 10
  year: 2009
  end-page: 1892
  ident: CR35
  article-title: Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddp109
– volume: 7
  start-page: 117
  issue: 3
  year: 2010
  end-page: 121
  ident: CR28
  article-title: Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-2010-0154
– volume: 15
  start-page: 7515
  issue: 18
  year: 2014
  end-page: 7520
  ident: CR9
  article-title: Adiponectin receptor 1 (ADIPOR1) rs1342387 polymorphism and risk of cancer: a meta-analysis
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2014.15.18.7515
– volume: 13
  start-page: 807
  issue: 5
  year: 2005
  end-page: 812
  ident: CR31
  article-title: An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance
  publication-title: Obes Res
  doi: 10.1038/oby.2005.91
– volume: 22
  start-page: 336
  issue: 4
  year: 2012
  end-page: 341
  ident: CR26
  article-title: Relationship between polymorphism sites of adiponection and it’s receptor gene and the susceptibility of colorectal cancer
  publication-title: Jiangsu Daxue Xuebao (Yixueban) (Chinese)
– volume: 3
  start-page: 176
  issue: 1
  year: 2012
  end-page: 180
  ident: CR29
  article-title: The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer
  publication-title: Oncol Lett
– volume: 20
  start-page: 1739
  issue: 9
  year: 2009
  end-page: 1751
  ident: CR24
  article-title: Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-009-9427-7
– volume: 7
  start-page: 177
  issue: 3
  year: 1986
  end-page: 188
  ident: CR14
  article-title: Meta-analysis in clinical trials
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(86)90046-2
– volume: 105
  start-page: 562
  issue: 4
  year: 2011
  end-page: 564
  ident: CR25
  article-title: Adiponectin gene and risk of colorectal cancer
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2011.259
– volume: 60
  start-page: 1530
  issue: 11
  year: 2011
  ident: 1710_CR30
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2011.03.020
– volume: 161
  start-page: 845
  issue: 6
  year: 2009
  ident: 1710_CR34
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0492
– volume: 160
  start-page: 933
  issue: 6
  year: 2009
  ident: 1710_CR22
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0039
– volume: 18
  start-page: 1889
  issue: 10
  year: 2009
  ident: 1710_CR35
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddp109
– volume: 6
  start-page: 341
  issue: 3
  year: 1987
  ident: 1710_CR15
  publication-title: Stat Med
  doi: 10.1002/sim.4780060325
– volume: 19
  start-page: 9
  issue: 1
  year: 2015
  ident: 1710_CR21
  publication-title: Genet Test Mol Biomarkers
  doi: 10.1089/gtmb.2014.0238
– volume: 18
  start-page: 417
  issue: 6
  year: 2014
  ident: 1710_CR5
  publication-title: Genet Test Mol Biomarkers
  doi: 10.1089/gtmb.2013.0493
– volume: 327
  start-page: 557
  issue: 7414
  year: 2003
  ident: 1710_CR13
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
– volume: 105
  start-page: 562
  issue: 4
  year: 2011
  ident: 1710_CR25
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2011.259
– volume: 24
  start-page: 1441
  issue: 7
  year: 2010
  ident: 1710_CR3
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2009-0498
– volume: 15
  start-page: 7515
  issue: 18
  year: 2014
  ident: 1710_CR9
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2014.15.18.7515
– volume: 35
  start-page: 195
  issue: 2
  year: 2014
  ident: 1710_CR20
  publication-title: Zhonghua Liu Xing Bing Xue Za Zhi (Chinese)
– volume: 3
  start-page: 176
  issue: 1
  year: 2012
  ident: 1710_CR29
  publication-title: Oncol Lett
  doi: 10.3892/ol.2011.443
– volume: 50
  start-page: 1088
  issue: 4
  year: 1994
  ident: 1710_CR16
  publication-title: Biometrics
  doi: 10.2307/2533446
– volume: 21
  start-page: 1539
  issue: 11
  year: 2002
  ident: 1710_CR12
  publication-title: Stat Med
  doi: 10.1002/sim.1186
– volume: 23
  start-page: 1127
  issue: 7
  year: 2012
  ident: 1710_CR18
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-012-9981-2
– volume: 13
  start-page: 807
  issue: 5
  year: 2005
  ident: 1710_CR31
  publication-title: Obes Res
  doi: 10.1038/oby.2005.91
– volume: 7
  start-page: 763
  issue: 10
  year: 2007
  ident: 1710_CR1
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2222
– volume: 40
  start-page: 1135
  issue: 2
  year: 2013
  ident: 1710_CR4
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-012-2154-2
– volume: 300
  start-page: 1523
  issue: 13
  year: 2008
  ident: 1710_CR10
  publication-title: JAMA
  doi: 10.1001/jama.300.13.1523
– volume: 33
  start-page: 581
  issue: 7
  year: 2009
  ident: 1710_CR11
  publication-title: Genet Epidemiol
  doi: 10.1002/gepi.20410
– volume: 12
  start-page: 94
  year: 2011
  ident: 1710_CR32
  publication-title: BMC Med Genet
  doi: 10.1186/1471-2350-12-94
– volume: 22
  start-page: 336
  issue: 4
  year: 2012
  ident: 1710_CR26
  publication-title: Jiangsu Daxue Xuebao (Yixueban) (Chinese)
– volume: 7
  start-page: 117
  issue: 3
  year: 2010
  ident: 1710_CR28
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-2010-0154
– volume: 46
  start-page: 459
  issue: 4
  year: 2003
  ident: 1710_CR2
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1074-z
– volume: 10
  start-page: 1113
  issue: 9
  year: 2013
  ident: 1710_CR7
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.6843
– volume: 34
  start-page: 769
  issue: 2
  year: 2013
  ident: 1710_CR6
  publication-title: Tumour Biol
  doi: 10.1007/s13277-012-0606-x
– volume: 8
  start-page: e67275
  issue: 6
  year: 2013
  ident: 1710_CR19
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0067275
– volume: 6
  start-page: 273015
  issue: 11
  year: 2011
  ident: 1710_CR23
  publication-title: PLoS One
– volume: 315
  start-page: 1533
  issue: 7121
  year: 1997
  ident: 1710_CR17
  publication-title: BMJ
  doi: 10.1136/bmj.315.7121.1533
– volume: 20
  start-page: 1739
  issue: 9
  year: 2009
  ident: 1710_CR24
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-009-9427-7
– volume: 35
  start-page: 2491
  issue: 3
  year: 2014
  ident: 1710_CR8
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-1329-3
– volume: 7
  start-page: 177
  issue: 3
  year: 1986
  ident: 1710_CR14
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(86)90046-2
– volume: 15
  start-page: 1375
  issue: 1
  year: 2014
  ident: 1710_CR27
  publication-title: BMC Med Genet
– volume: 64
  start-page: 1324
  issue: 10
  year: 2015
  ident: 1710_CR33
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2015.06.013
– reference: 18827209 - JAMA. 2008 Oct 1;300(13):1523-31
– reference: 25516230 - BMC Med Genet. 2014 Dec 17;15:137
– reference: 19264763 - Hum Mol Genet. 2009 May 15;18(10 ):1889-92
– reference: 17882277 - Nat Rev Cancer. 2007 Oct;7(10):763-77
– reference: 22565227 - Cancer Causes Control. 2012 Jul;23(7):1127-38
– reference: 12687327 - Diabetologia. 2003 Apr;46(4):459-69
– reference: 21829206 - Br J Cancer. 2011 Aug 9;105(4):562-4
– reference: 23826253 - PLoS One. 2013 Jun 27;8(6):e67275
– reference: 21749709 - BMC Med Genet. 2011 Jul 12;12:94
– reference: 19755407 - Eur J Endocrinol. 2009 Dec;161(6):845-52
– reference: 21263187 - Cancer Biomark. 2010;7(3):117-21
– reference: 19278015 - Genet Epidemiol. 2009 Nov;33(7):581-98
– reference: 19273568 - Eur J Endocrinol. 2009 Jun;160(6):933-40
– reference: 25292021 - Asian Pac J Cancer Prev. 2014;15(18):7515-20
– reference: 15919831 - Obes Res. 2005 May;13(5):807-12
– reference: 20444885 - Mol Endocrinol. 2010 Jul;24(7):1441-52
– reference: 3802833 - Control Clin Trials. 1986 Sep;7(3):177-88
– reference: 12958120 - BMJ. 2003 Sep 6;327(7414):557-60
– reference: 7786990 - Biometrics. 1994 Dec;50(4):1088-101
– reference: 23065236 - Mol Biol Rep. 2013 Feb;40(2):1135-44
– reference: 24720830 - Genet Test Mol Biomarkers. 2014 Jun;18(6):417-24
– reference: 12111919 - Stat Med. 2002 Jun 15;21(11):1539-58
– reference: 23869187 - Int J Med Sci. 2013 Jul 04;10(9):1113-20
– reference: 24293390 - Tumour Biol. 2014 Mar;35(3):2491-6
– reference: 21632074 - Metabolism. 2011 Nov;60(11):1530-8
– reference: 9432252 - BMJ. 1997 Dec 6;315(7121):1533-7
– reference: 3616287 - Stat Med. 1987 Apr-May;6(3):341-50
– reference: 22740876 - Oncol Lett. 2012 Jan;3(1):176-180
– reference: 22087284 - PLoS One. 2011;6(11):e27301
– reference: 19760027 - Cancer Causes Control. 2009 Nov;20(9):1739-51
– reference: 25489716 - Genet Test Mol Biomarkers. 2015 Jan;19(1):9-13
– reference: 26169471 - Metabolism. 2015 Oct;64(10):1324-33
– reference: 24739564 - Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Feb;35(2):195-9
– reference: 23225349 - Tumour Biol. 2013 Apr;34(2):769-78
SSID ssj0057624
Score 1.7094678
SecondaryResourceType review_article
Snippet Numerous epidemiological studies have studied the association of adiponectin(ADIPOQ) gene and adiponectin receptor(ADIPOR) gene polymorphisms with risk of...
Summary Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with...
Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of...
SourceID wanfang
proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 161
SubjectTerms Adiponectin - genetics
Colorectal Neoplasms - ethnology
Colorectal Neoplasms - genetics
Ethnic Groups - genetics
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Insulin Resistance
Medicine
Medicine & Public Health
Meta分析
Polymorphism, Single Nucleotide
Receptors, Adiponectin - genetics
关联
受体
变异
基因多态性
结直肠癌
胰岛素抵抗
风险
Title Association of ADIPOQ and ADIPOR Variants with Risk of Colorectal Cancer:A Meta-analysis
URI http://lib.cqvip.com/qk/85740A/201702/672208003.html
https://link.springer.com/article/10.1007/s11596-017-1710-3
https://www.ncbi.nlm.nih.gov/pubmed/28397042
https://www.proquest.com/docview/1886753081
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201702002
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6VVEJcqj54mNBokXoqsuS3vb1Z0BJalRZEpPa02mdQWxxI3Kr998zEdhIEqsQth91Zab717DeZ2W8B9iKtXIBwYloitZ_wyPlKmcJPSEscEwAjNVV0Tz9nw1FyfJFetPe4Z123e1eSnEfq5WU3PHkp-yVRQwoeT2A9xdSdtvUoKrvwi_y5eck2y6mtMo67Uua_TJCgwvdJNf6Fy_15MP3FNlcqpfP7PZWT1XjlKDrahI2WQ7KyAX0L1my1DU9P2yr5Dlyu-JxNHCs_fDo_-8JkZZqfX9kdZsjUAMPob1hG7eU0jgSsKQCibU2bYXrASvbD1tKXrXTJcxgdHX57P_TbJxR8jZla7aeFCaXUiQqkylTADfEJFXJZcI2xKsuctuE8MXSWIxcyiuepQQflmdLW8fgF9KpJZV8BC5Ap5omLXBraRBskEkFuExsFhYp54kIP-gtfip-NVIZAECLipLEHQeddoVv1cXoE40YsdZMJHIFrCwJH4JT9xZTO3iOD33aQCfxAqOohKzu5nYmwKDApipH6ePCywXJhDrkVzzFsefCuA1e03_DssbX2WvyXg-urh2tzf68EOiTMA2p9ef1fRvvwjGY2TUFvoFdPb-0u8p1aDWC9_Hh5cjiY7_Pf2efzpg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZbxMxEB5BKgEv3Ecoh5H6BNpqD-9h3iJoSWlTDqVS-2T5LKKwgWaDCr-emew6CYcq9W0f7LHsGY-_2Rl_BthIjfYxqhPDEmUiLlIfaW2riBOXOAYAVhnK6I72i-EBf3uYH3b3uKeh2j2kJOeeennZDU9ein6J1JCcx2VY4xiC5z1YG7w52t0KDhgRdPuWbVFSYWWWhWTm_4QQpcKnSX38HQf882j6B2-u5ErnN3xqr-rjlcNo-waMwzTaGpSTzVmjN82vvxgeLzjPm3C9A6ds0FrTLbjk6ttwZdSl3-_A0Yoy2cSzweud9-8-MFXb9vMj-4GhN1XWMPq_y6hundoRMzZ5VpRtyMpOX7IB--oaFamOE-UuHGxvjV8No-5thshgCNhEeWUTpQzXsdKFjoUloKIToSph0AkWhTcumUec3gkEWVaLMrc4qbLQxnmR3YNePandA2AxQtCS-9TniePGIkKJS8ddGlc6E9wnfVhfqEh-azk4JOo2JbCb9SEOSpOmozWn1zW-yCUhMy2oxLElLajELs8XXYK8cxo_C5YgcedROkXVbjKbyqSqMNrKEFP14X5rIgtxCNpEif6wDy-CkmXnHKbnjbXRmdWycfP554k9O9MSFyQpY6qpeXghoU_h6nA82pN7O_u763CNpLSVR4-g15zO3GMEVY1-0m2i3zJ6EdU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LTxsxEB61qYR6QdDSEsLDlThRrdhXdtfcIiCCtryqRqIny0-qAg6QBcG_Zya7m6RqhdTbHuyxNGOPv9kZfwOwGWvlQjQnhiVSBymPXaCUKYKUuMQxADBSU0b36Dg7GKRfzrvndZ_TUVPt3qQkqzcNxNLky-0b47anD9_wFqZImAgOyZG8hjfojSOq6RrEvcYVI5auutpmOZVYJkmT1vyXCCJX-DX0F7e49J-X1F_IcyZrOn7r4530FzPXUn8B5ms8yXrVBliEV9a_g7mjOmP-Hn7O6J8NHevtHZ6enDHpTfX5nT1gtEzFMIx-yTIqNadxRGZNzhBla9oYdzusx65tKQNZ05gswaC__2P3IKjbKQQao7Yy6BYmklKnKpQqUyE3hC1UxGXBNfqtLHPaRuMg0VmOuMgonncNKijPlLaOJx-g5YfeLgMLETXmqYtdN7KpNggqwtymNg4LlfDURW3oTHQpbiraDIFGiAmfJm0IG-0KXTORU0OMKzHlUCbjCFxbkHEETtmaTGnkvTD4U2MygYeFMiDS2-H9SERFgQFSgjCoDR8rW07EIc7iObqwNnxujCvq8zx6aa3N2v7TweXvp0vz-KgEKiTKQyqDWfkvoRswd7rXF98Oj7924C0JqWqFVqFV3t3bNYRBpVofb_VnJ575QQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+ADIPOQ+and+ADIPOR+variants+with+risk+of+colorectal+cancer%3A+A+meta-analysis&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Tan%2C+Xuan&rft.au=Wang%2C+Guo-bin&rft.au=Tang%2C+Yong&rft.au=Bai%2C+Jie&rft.date=2017-04-01&rft.issn=1672-0733&rft.volume=37&rft.issue=2&rft.spage=161&rft.epage=171&rft_id=info:doi/10.1007%2Fs11596-017-1710-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11596_017_1710_3
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg